Peter Greaney

Peter Greaney is an accomplished professional with an extensive background in the biopharmaceutical industry and a strong educational foundation in Molecular and Cellular Biology.

He earned his PhD in Molecular and Cellular Biology from the University of Nottingham and his BSc in Cell Biology from the University of East Anglia.

Peter currently holds the position of Head of Corporate Development at ADC Therapeutics, where he plays a pivotal role in driving strategic initiatives and fostering business growth.

Prior to his current role, he served as a Judge & Mentor at MassChallenge Switzerland, demonstrating his commitment to supporting and nurturing emerging talent in the entrepreneurial ecosystem.

Peter has also held various key positions at Celgene, including Director of Business Development, Strategy and Operations, Associate Director of Business Development, Manager of Market Research and Business Intelligence, and Senior Manager in Medical Development/Affairs.

His diverse experience at Celgene provided him with a comprehensive understanding of the industry landscape and a proven track record of successful project execution.

Before joining Celgene, Peter Greaney worked as a Senior Scientist at Apoxis and as a PHD Researcher at Servier, where he honed his scientific skills and contributed to research advancements in the field.

With a solid academic background and a wealth of professional experience, Peter Greaney continues to make significant contributions to the biopharmaceutical sector through his leadership and strategic expertise.